GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INVO Fertility, Inc. (IVF) | 8/17/2026 8:39:25 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $2,175,485 +16.7% | Assets $25,834,562 | EPS $0.35 | Export Earnings Model | |
| INVO Fertility, Inc. (IVF) | 8/14/2026 5:33:56 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $2,175,485 +16.7% | Assets $25,834,562 | EPS $0.35 | |
| INVO Fertility, Inc. (IVF) | 6/23/2026 4:06:49 PM | View | Proxy | SEC | Y 2025 | ||||||
| INVO Fertility, Inc. (IVF) | 6/22/2026 9:15:43 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $2,015,225 +23.1% | Assets $24,656,147 | EPS -$3.38 | |
| INVO Fertility, Inc. (IVF) | 6/22/2026 9:06:04 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $2,015,225 +23.1% | Assets $24,656,147 | EPS -$3.38 | Export Earnings Model | |
| INVO Fertility, Inc. (IVF) | 6/12/2026 4:41:06 PM | Micro | View | Financials | 10-K/A | SEC | Y 2025 ending: 12/31/2025 | Rev: $6,841,250 +4.7% | Assets $20,220,124 | EPS -$214.64 | |
| INVO Fertility, Inc. (IVF) | 6/2/2026 8:45:31 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $6,841,250 +4.7% | Assets $20,220,124 | EPS -$214.64 | |
| INVO Fertility, Inc. (IVF) | 6/2/2026 8:41:39 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $1,583,317 -6.1% | Assets $20,220,124 | EPS -$196.81 | Export Earnings Model | |
| INVO Fertility, Inc. (IVF) | 12/18/2025 4:07:30 PM | View | Proxy | SEC | Y 2024 | ||||||
| INVO Fertility, Inc. (IVF) | 11/17/2025 8:44:10 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $1,757,094 +22.6% | Assets $18,832,198 | EPS -$0.77 | Export Earnings Model | |
| INVO Fertility, Inc. (IVF) | 11/17/2025 7:12:57 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $1,757,094 +22.6% | Assets $18,832,198 | EPS -$0.77 | |
| INVO Fertility, Inc. (IVF) | 8/15/2025 2:03:54 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $1,863,654 +1.5% | Assets $19,319,239 | EPS -$13.30 | Export Earnings Model | |
| INVO Fertility, Inc. (IVF) | 8/14/2025 5:34:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $1,863,654 +1.5% | Assets $19,319,239 | EPS -$13.30 | |
| INVO Fertility, Inc. (IVF) | 6/4/2025 4:07:53 PM | View | Proxy | SEC | Y 2024 | ||||||
| INVO Fertility, Inc. (IVF) | 5/21/2025 6:01:29 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $1,637,185 +3.9% | Assets $31,744,110 | EPS -$12.53 | Export Earnings Model | |
| INVO Fertility, Inc. (IVF) | 5/20/2025 4:15:16 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $1,637,185 +3.9% | Assets $31,744,110 | EPS -$12.53 | |
| INVO Fertility, Inc. (IVF) | 5/19/2025 4:52:18 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Rev: $6,532,000 +116.3% | Assets $46,449,182 | EPS -$30.19 | |
| INVO Fertility, Inc. (IVF) | 4/30/2025 9:01:57 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $1,685,966 +22.0% | Assets $46,449,182 | EPS -$28.55 | Export Earnings Model | |
| INVO Fertility, Inc. (IVF) | 4/30/2025 6:15:06 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $6,532,000 +116.3% | Assets $46,449,182 | EPS -$30.19 | |
| NAYA Biosciences, Inc. (IVF) | 3/12/2025 4:08:08 PM | View | Proxy | SEC | Y 2024 | ||||||
| NAYA Biosciences, Inc. (IVF) | 2/11/2025 2:59:51 PM | View | Proxy | SEC | Y 2024 | ||||||
| NAYA Biosciences, Inc. (IVF) | 11/19/2024 4:32:31 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $1,433,151 +47.0% | Assets $17,019,489 | EPS -$0.42 | |
| NAYA Biosciences, Inc. (IVF) | 11/19/2024 4:22:27 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $1,836,597 +481.4% | Assets $17,754,698 | EPS -$0.62 | |
| NAYA Biosciences, Inc. (IVF) | 11/19/2024 4:22:25 PM | Micro | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Rev: $3,020,575 +267.4% | Assets $18,505,916 | EPS -$5.13 | |
| INVO Bioscience, Inc. (IVF) | 8/14/2024 4:09:30 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $1,836,597 +481.4% | Assets $17,754,698 | EPS -$0.62 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 8/14/2024 9:18:03 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $1,836,597 +481.4% | Assets $17,754,698 | EPS -$0.62 | |
| INVO Bioscience, Inc. (IVF) | 5/15/2024 4:52:25 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $1,576,286 +352.9% | Assets $18,317,765 | EPS -$0.42 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 5/15/2024 4:17:30 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $1,576,286 +352.9% | Assets $18,317,765 | EPS -$0.42 | |
| INVO Bioscience, Inc. (IVF) | 4/29/2024 4:54:39 PM | Micro | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Rev: $3,020,575 +267.4% | Assets $18,505,916 | EPS -$5.13 | |
| INVO Bioscience, Inc. (IVF) | 4/17/2024 5:17:47 PM | Micro | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Rev: $3,020,575 +267.4% | Assets $18,505,916 | EPS -$5.13 | |
| INVO Bioscience, Inc. (IVF) | 4/16/2024 5:07:26 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $3,020,575 +267.4% | Assets $18,505,916 | EPS -$5.13 | |
| INVO Bioscience, Inc. (IVF) | 4/16/2024 4:57:38 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $1,381,754 +396.8% | Assets $18,505,916 | EPS $0.63 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 3/27/2024 5:39:59 PM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Rev: $822,196 -80.2% | Assets $4,103,715 | EPS -$17.97 | |
| INVO Bioscience, Inc. (IVF) | 11/24/2023 1:10:27 PM | View | Proxy | SEC | Y 2022 | ||||||
| INVO Bioscience, Inc. (IVF) | 11/13/2023 4:17:11 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $974,894 +314.3% | Assets $19,476,171 | EPS -$0.70 | |
| INVO Bioscience, Inc. (IVF) | 11/13/2023 4:14:54 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $974,894 +314.3% | Assets $19,476,171 | EPS -$0.70 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 9/1/2023 9:56:37 AM | View | Proxy | SEC | Y 2022 | ||||||
| INVO Bioscience, Inc. (IVF) | 8/14/2023 4:22:56 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $315,902 +116.2% | Assets $6,638,894 | EPS -$3.06 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 8/14/2023 4:17:54 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $315,902 +116.2% | Assets $6,638,894 | EPS -$3.06 | |
| INVO Bioscience, Inc. (IVF) | 5/15/2023 4:23:59 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $348,025 +114.0% | Assets $6,151,156 | EPS -$4.10 | |
| INVO Bioscience, Inc. (IVF) | 5/15/2023 4:16:01 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $348,025 +114.0% | Assets $6,151,156 | EPS -$4.10 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 4/27/2023 5:39:15 PM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Rev: $822,196 -80.2% | Assets $4,103,715 | EPS -$17.97 | |
| INVO Bioscience, Inc. (IVF) | 4/17/2023 4:23:49 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $822,196 -80.2% | Assets $4,103,715 | EPS -$17.97 | |
| INVO Bioscience, Inc. (IVF) | 4/17/2023 4:12:22 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $278,142 -90.9% | Assets $4,103,715 | EPS -$4.55 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 3/30/2023 5:27:12 PM | View | Financials | Earnings (Prelim) | SEC | Y 2022 | Export Earnings Model | ||||
| INVO Bioscience, Inc. (IVF) | 11/14/2022 4:26:24 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $235,321 +7.5% | Assets $4,678,275 | EPS -$4.19 | |
| INVO Bioscience, Inc. (IVF) | 11/14/2022 4:22:21 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $235,321 +7.5% | Assets $4,678,275 | EPS -$4.19 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 8/25/2022 1:50:49 PM | View | Proxy | SEC | Y 2021 | ||||||
| INVO Bioscience, Inc. (IVF) | 8/15/2022 4:56:42 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $146,135 -29.9% | Assets $6,424,873 | EPS -$4.62 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 8/15/2022 4:26:17 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $146,135 -29.9% | Assets $6,424,873 | EPS -$4.62 | |
| INVO Bioscience, Inc. (IVF) | 8/15/2022 4:07:41 PM | View | Financials | Earnings | WIRE | 2Q 2022 | Rev $146,135 -29.9% | Assets $6,424,873 | EPS -$4.62 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 5/17/2022 6:05:54 AM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $162,598 -76.2% | Assets $8,520,233 | EPS -$4.60 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 5/16/2022 4:29:56 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $162,598 -76.2% | Assets $8,520,233 | EPS -$4.60 | |
| INVO Bioscience, Inc. (IVF) | 3/31/2022 4:57:54 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $3,048,247 +1,450.7% | Assets $10,466,380 | EPS $0.03 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 3/31/2022 4:15:26 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $4,160,116 +301.1% | Assets $10,466,380 | EPS -$0.63 | |
| INVO Bioscience, Inc. (IVF) | 11/16/2021 6:15:43 AM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $218,874 -34.9% | Assets $8,145,547 | EPS -$0.24 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 11/16/2021 4:02:25 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $218,874 -34.9% | Assets $8,145,547 | EPS -$0.24 | |
| INVO Bioscience, Inc. (IVF) | 8/16/2021 4:16:02 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $208,472 -15.3% | Assets $9,931,188 | EPS -$0.17 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 8/16/2021 4:14:07 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $208,472 -15.3% | Assets $9,931,188 | EPS -$0.17 | |
| INVO Bioscience, Inc. (IVF) | 7/28/2021 6:08:09 AM | View | Proxy | SEC | Y 2020 | ||||||
| INVO Bioscience, Inc. (IVF) | 5/18/2021 6:02:46 AM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $684,523 +164.7% | Assets $10,190,179 | EPS -$0.25 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 5/17/2021 4:31:36 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $684,523 +164.7% | Assets $10,190,179 | EPS -$0.25 | |
| INVO Bioscience, Inc. (IVF) | 3/30/2021 5:24:09 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $196,572 -40.2% | Assets $10,947,343 | EPS -$0.60 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 3/30/2021 5:15:42 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $1,037,286 -29.9% | Assets $10,947,343 | EPS -$1.52 | |
| INVO Bioscience, Inc. (IVF) | 11/20/2020 4:16:44 PM | View | Proxy | SEC | Y 2019 | ||||||
| INVO Bioscience, Inc. (IVF) | 11/16/2020 5:04:12 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $336,071 +10.7% | Assets $1,688,992 | EPS -$0.36 | |
| INVO Bioscience, Inc. (IVF) | 8/13/2020 4:54:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $246,072 +37.8% | EPS -$0.27 | ||
| INVO Bioscience, Inc. (IVF) | 5/15/2020 5:31:39 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $258,571 | EPS -$0.29 | ||
| INVO Bioscience, Inc. (IVF) | 3/30/2020 5:00:16 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | ||||
| INVO Bioscience, Inc. (IVF) | 3/30/2020 4:44:48 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $328,572 | Assets $1,795,479 | EPS -$0.16 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 11/15/2019 5:29:10 PM | View | Proxy | SEC | Y 2018 | ||||||
| INVO Bioscience, Inc. (IVF) | 11/14/2019 9:47:29 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $303,571 +142.8% | Assets $2,564,804 | EPS -$0.15 | |
| INVO Bioscience, Inc. (IVF) | 11/14/2019 9:08:33 AM | View | Financials | Earnings | WIRE | 3Q 2019 | Rev $303,571 +142.8% | Assets $2,564,804 | EPS -$0.15 | Export Earnings Model | |
| INVO Bioscience, Inc. (IVF) | 8/14/2019 5:46:34 PM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $178,571 +62.0% | Assets $3,395,779 | Export Earnings Model | ||
| INVO Bioscience, Inc. (IVF) | 8/14/2019 4:28:25 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $178,571 +62.0% | Assets $3,395,779 | ||
| INVO Bioscience, Inc. (IVF) | 5/15/2019 4:35:13 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $3,503,231 | |||
| INVO Bioscience, Inc. (IVF) | 5/15/2019 4:23:43 PM | View | Financials | Earnings | WIRE | 1Q 2019 | Assets $3,503,231 | Export Earnings Model | |||
| INVO Bioscience, Inc. (IVF) | 4/16/2019 4:28:39 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | ||||
| INVO Bioscience, Inc. (IVF) | 4/16/2019 4:16:00 PM | View | Financials | Earnings | WIRE | Y 2018 | Export Earnings Model | ||||
| INVO Bioscience, Inc. (IVF) | 11/14/2018 4:42:05 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $125,035 +83.3% | Assets $919,991 | ||
| INVO Bioscience, Inc. (IVF) | 11/14/2018 4:15:55 PM | View | Financials | Earnings | WIRE | 3Q 2018 | Rev $125,035 +83.3% | Assets $919,991 | Export Earnings Model | ||
| INVO Bioscience, Inc. (IVF) | 8/14/2018 4:40:00 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $110,210 +37.2% | Assets $1,143,241 | EPS -$0.01 | |
| INVO Bioscience, Inc. (IVF) | 5/15/2018 8:41:46 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $104,140 +99.3% | Assets $307,670 | ||
| INVO Bioscience, Inc. (IVF) | 3/29/2018 10:25:05 AM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $282,145 +454.3% | Assets $266,413 | ||
| INVO Bioscience, Inc. (IVF) | 11/14/2017 8:45:53 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $68,220 +282.6% | Assets $200,432 | ||
| INVO Bioscience, Inc. (IVF) | 9/5/2017 10:26:06 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $17,831 +609.6% | Assets $389,519 | ||
| INVO Bioscience, Inc. (IVF) | 9/5/2017 10:26:06 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $5,446 -1.9% | Assets $455,004 | EPS -$0.01 | |
| INVO Bioscience, Inc. (IVF) | 9/5/2017 10:16:02 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $18,107 +399.5% | Assets $549,277 | ||
| INVO Bioscience, Inc. (IVF) | 8/10/2017 4:17:00 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $80,330 +1,375.0% | Assets $181,785 | ||
| INVO Bioscience, Inc. (IVF) | 5/15/2017 1:15:12 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $52,240 +188.5% | Assets $194,498 | ||
| INVO Bioscience, Inc. (IVF) | 4/20/2017 4:16:02 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $50,901 +335.5% | Assets $286,226 | EPS -$0.02 | |
| INVO Bioscience, Inc. (IVF) | 3/17/2017 4:17:30 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $11,689 -29.5% | Assets $579,786 | EPS -$0.04 | |
| INVO Bioscience, Inc., (IVF) | 11/21/2011 4:30:34 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | ||||
| INVO Bioscience, Inc., (IVF) | 8/22/2011 4:49:36 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 |